Prednisolone is a synthetic corticosteroid acting on both hydrosaline balance and metabolism that is liable to fraudulent administration to meat-producing animals for growth-promoting purposes. Its use outside strict therapeutic control and prescription is banned by the European legislation, but official controls are hampered by its negligible direct excretion into the urinary matrix. Recent studies reported on a potential endogenous origin of prednisolone in animals subjected to stressful conditions, accounting for its occasional detection in control urines. The objective of the present study was the identification and quantification of prednisolone urinary metabolites, to be used as illicit treatment biomarkers, in place of the parent drug. An LC-MS/MS screening was conducted on urine samples collected from a bullock i.m. administered with prednisolone acetate using a therapeutic protocol (2 x 0.52 mg kg-1 at 48h interval). Four prednisolone metabolites were identified, including 20β-dihydroprednisolone, 20α-dihydroprednisolone, 6β-hydroxyprednisolone and 20β-dihydroprednisone; the first was detected at relatively high concentrations. An existing quantitative LC-MS/MS method was expanded and re-validated, to include these metabolites. The new analytical method proved sensitive (LODs: 0.35-0.42 ng ml-1 ) and specific, and was applied to urine samples collected from eight beef cattle subjected to low-dosage oral administration of prednisolone acetate for a 35-days period, as in standard growth-promoting treatments. 20β-dihydroprednisolone was detected in all urine samples collected during the treatment, at relatively high concentration (1.2-27 ng ml-1 ), whereas the prednisolone concentration was virtually negligible (<0.7 ng ml-1 ). 20β-dihydroprednisolone was no longer present in almost all samples collected six days after the end of the treatment, but trace amounts of this metabolite were found in two urine samples from control animals. 20β-dihydroprednisolone is proposed as an effective biomarker 24 to test illegal growth-promoting treatments with prednisolone in meat cattle, alternatively to the parent drug.

Determination of prednisolone metabolites in beef cattle

CAPRA, PIERLUIGI;CANNIZZO, FRANCESCA TIZIANA;BIOLATTI, Bartolomeo;NEBBIA, Carlo;VINCENTI, Marco
2013-01-01

Abstract

Prednisolone is a synthetic corticosteroid acting on both hydrosaline balance and metabolism that is liable to fraudulent administration to meat-producing animals for growth-promoting purposes. Its use outside strict therapeutic control and prescription is banned by the European legislation, but official controls are hampered by its negligible direct excretion into the urinary matrix. Recent studies reported on a potential endogenous origin of prednisolone in animals subjected to stressful conditions, accounting for its occasional detection in control urines. The objective of the present study was the identification and quantification of prednisolone urinary metabolites, to be used as illicit treatment biomarkers, in place of the parent drug. An LC-MS/MS screening was conducted on urine samples collected from a bullock i.m. administered with prednisolone acetate using a therapeutic protocol (2 x 0.52 mg kg-1 at 48h interval). Four prednisolone metabolites were identified, including 20β-dihydroprednisolone, 20α-dihydroprednisolone, 6β-hydroxyprednisolone and 20β-dihydroprednisone; the first was detected at relatively high concentrations. An existing quantitative LC-MS/MS method was expanded and re-validated, to include these metabolites. The new analytical method proved sensitive (LODs: 0.35-0.42 ng ml-1 ) and specific, and was applied to urine samples collected from eight beef cattle subjected to low-dosage oral administration of prednisolone acetate for a 35-days period, as in standard growth-promoting treatments. 20β-dihydroprednisolone was detected in all urine samples collected during the treatment, at relatively high concentration (1.2-27 ng ml-1 ), whereas the prednisolone concentration was virtually negligible (<0.7 ng ml-1 ). 20β-dihydroprednisolone was no longer present in almost all samples collected six days after the end of the treatment, but trace amounts of this metabolite were found in two urine samples from control animals. 20β-dihydroprednisolone is proposed as an effective biomarker 24 to test illegal growth-promoting treatments with prednisolone in meat cattle, alternatively to the parent drug.
2013
30
6
1044
1054
http://www.ncbi.nlm.nih.gov/pubmed/23510304
http://www.tandfonline.com/doi/full/10.1080/19440049.2013.777975
prednisolone; metabolites; cattle; LC-MS
M. Leporati; P. Capra; F.T. Cannizzo; B. Biolatti; C. Nebbia; M. Vincenti
File in questo prodotto:
File Dimensione Formato  
1110504-aperto.pdf

Open Access dal 02/06/2014

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 585.82 kB
Formato Adobe PDF
585.82 kB Adobe PDF Visualizza/Apri
1110504.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 856.3 kB
Formato Adobe PDF
856.3 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/130147
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact